baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Morgan Stanley Knock-Out PGR/ DE000ME69CB1 /

2024-06-26 9:49:58 PM	Chg.-0.07	Bid10:00:37 PM	Ask10:00:37 PM	Underlying	Strike price	Expiration date	Option type
4.33EUR	-1.59%	- Bid Size: -	- Ask Size: -	Progressive Corporat...	161.9244 USD	2078-12-31	Call

GlobeNewswire 06-26 Dupixent® (dupilumab) Positive Phase 3 Data in Children 1 to 11 Years of Age with Eosinophilic Esoph...

GlobeNewswire 06-26 Press Release: Dupixent positive phase 3 data in children one to 11 years of age with eosinophilic e...

GlobeNewswire 06-26 Discover the $CIRX (Circular Protocol) Listing on XT

GlobeNewswire 06-26 Specialists in Gastroenterology and GI Alliance Begin Prescribing Groundbreaking Rezdiffra for Fatty...

GlobeNewswire 06-26 ORYZON Announces Presentation of Final Data From PORTICO, Vafidemstat’s Global Phase IIb Trial in Bo...

GlobeNewswire 06-26 Tiziana Life Sciences to Dose First Patient with Moderate Alzheimer’s Disease with Foralumab

GlobeNewswire 06-26 Beam Therapeutics Announces First Patient Dosed in the Phase 1/2 Study of BEAM-302 in Alpha-1 Antitr...

GlobeNewswire 06-25 argenx Highlights Breadth of Autoimmune Pipeline with New Multifocal Motor Neuropathy Data at 2024 P...

GlobeNewswire 06-25 AskBio Initiates Recruitment to its Phase 2 Parkinson’s Disease Trial

GlobeNewswire 06-24 Enlivex Announces the Dosing of the First Patient in a Randomized, Placebo-Controlled Phase I/II Tri...

GlobeNewswire 06-24 4DMT Announces FDA Clearance of IND Application for 4D-175 Genetic Medicine for the Treatment of Geo...

GlobeNewswire 06-24 Entrada Therapeutics Reports Positive Preliminary Data in Healthy Volunteers from Phase 1 ENTR-601-4...

GlobeNewswire 06-19 Opthea A$55.0m (US$36.9m¹) Retail Entitlement Offer Opens

GlobeNewswire 06-18 Afamelanotide in fair-skinned Parkinson’s patients

GlobeNewswire 06-14 Progressive Reports May 2024 Results

GlobeNewswire 06-13 Dyne Therapeutics Presents New Preclinical Data for its Facioscapulohumeral Muscular Dystrophy Progr...

GlobeNewswire 06-12 Ultragenyx Announces Plans to File for Accelerated Approval of UX111 for the Treatment of Sanfilippo...

GlobeNewswire 06-12 Belite Bio Receives Sakigake (Pioneer Drug) Designation of Tinlarebant for Stargardt Disease in Japa...

GlobeNewswire 06-11 Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D ...

GlobeNewswire 06-11 Processa Pharmaceuticals Announces Positive Efficacy Results from Preliminary Evaluation of Phase 1b...

GlobeNewswire 06-11 FDA Accepts Tiziana Life Sciences Fast Track Designation Submission for Treatment of Multiple Sclero...

GlobeNewswire 06-10 LifeWallet’s Proprietary Data System is Instrumental in Class Certification Against USAA Property an...

GlobeNewswire 06-10 SYFOVRE® (pegcetacoplan injection) Preserved Visual Function at 36 Months in GALE Extension Study in...

TeleTrader 06-09 EP updated results, EPP with 189 seats

TeleTrader 06-09 EPP's Weber claims party victory in EP election

Morgan Stanley Knock-Out PGR/ DE000ME69CB1 /

If you wish to receive reply to your feedback, please provide your email address.